Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash Flows from Operating Activities:
Net income	$ 3,620	$ 1,778
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	982	415
Provision for bad debts	(94)	175
Compensatory element of stock issuances	19
Stock issued for costs and expenses	110
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivables	(1,974)	(979)
Notes receivable	35	33
Costs and estimated earnings in excess of billings on uncompleted contracts		(30)
Inventories	(49)	(322)
Prepaid expenses and other current assets	210	6
Other assets	40	(24)
Increase (decrease) in operating liabilities, net:
Accounts payable	(58)	112
Other current liabilities	1,008	536
Customer advances	60	16
Other liabilities	(29)	(10)
Due to related medical practices	(1)	2
Income tax payable	(20)	(75)
Net cash provided by operating activities	(3,859)	(1,633)
Cash Flows from Investing Activities:
Purchases of property and equipment	(182)	(211)
Cost of patents	(47)	(36)
Net cash used in investing activities	(229)	(247)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(970)	(266)
Distributions to non controlling interests	(1,295)	(249)
Repayment of notes receivable from employee Stockholders	2	2
Net cash provided by (used in) financing activities	(2,263)	(513)
Net (Decrease) Increase in Cash and Cash Equivalents	1,367	873
Cash and Cash Equivalents - Beginning of Period	7,871	12,032
Cash and Cash Equivalents - End of Period	$ 9,238	$ 12,905